Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab

被引：0
|
作者：
Zaremba, A. [1 ]
Chorti, E. [1 ]
Jockenhoefer, F. [1 ]
Albrecht, M. [1 ]
Placke, J. M. [1 ]
Knispel, S. [1 ]
Schadendorf, D. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ]
Ugurel, S. [1 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P37
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [31] Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
    Gambichler, Thilo
    Stockfleth, E.
    Susok, L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [32] Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
    Zimmer, Lisa
    Apuri, Susmitha
    Eroglu, Zeynep
    Kottschade, Lisa A.
    Forschner, Andrea
    Gutzmer, Ralf
    Schlaak, Max
    Heinzerling, Lucie
    Krackhardt, Angela M.
    Loquai, Carmen
    Markovic, Svetomir N.
    Joseph, Richard W.
    Markey, Kelly
    Utikal, Jochen S.
    Weishaupt, Carsten
    Goldinger, Simone M.
    Sondak, Vernon K.
    Zager, Jonathan S.
    Schadendorf, Dirk
    Khushalani, Nikhil I.
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 47 - 55
  • [33] Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038
    Ribas, Antoni
    Martin-Algarra, Salvador
    Bhatia, Shailender
    Hwu, Wen-Jen
    Slingluff, Craig L.
    Sharfman, William H.
    Hodi, F. Stephen
    Urba, Walter J.
    Luke, Jason J.
    Haanen, John B.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Young, Tina C.
    Qureshi, Anila
    Horak, Christine E.
    CANCER RESEARCH, 2017, 77
  • [34] Nivolumab plus ipilimumab for advanced MPM
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E76 - E76
  • [35] Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
    Peter L. Quon
    Ying Xiao
    Sonja Sorensen
    Amir Abbas Tahami Monfared
    PharmacoEconomics - Open, 2019, 3 : 321 - 331
  • [36] Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
    Quon, Peter L.
    Xiao, Ying
    Sorensen, Sonja
    Monfared, Amir Abbas Tahami
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 321 - 331
  • [37] Ipilimumab after nivolumab therapy for melanoma patients in Asia
    Tsutsumida, A.
    Yamazaki, N.
    Takahashi, A.
    Namikawa, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
    Sznol, Mario
    Ferrucci, Pier Francesco
    Hogg, David
    Atkins, Michael B.
    Wolter, Pascal
    Guidoboni, Massimo
    Lebbe, Celeste
    Kirkwood, John M.
    Schachter, Jacob
    Daniels, Gregory A.
    Hassel, Jessica
    Cebon, Jonathan
    Gerritsen, Winald
    Atkinson, Victoria
    Thomas, Luc
    McCaffrey, John
    Power, Derek
    Walker, Dana
    Bhore, Rafia
    Jiang, Joel
    Hodi, F. Stephen
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3815 - +
  • [39] Pathology of durable stable disease in melanoma patients treated with ipilimumab, nivolumab, or ipilimumab, and nivolumab combination therapy.
    Buchbinder, Elizabeth Iannotti
    Pfaff, Kathleen L.
    Manos, Michael P.
    Ouyang, Olivia
    Ott, Patrick Alexander
    Rodig, Scott J.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma
    Kuriyama, Haruka
    Fukushima, Satoshi
    Nakahara, Satoshi
    Kanemaru, Hisashi
    Miyashita, Azusa
    Aoi, Jun
    Tomita, Yusuke
    Kawasaki, Takeshi
    Nosaka, Kisato
    Ihn, Hironobu
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : E235 - E237
12345